2020 National Conference Registration is Now Open
Are you an ovarian cancer survivor, patient, or caregiver? Don’t miss YOUR chance to learn what’s new in ovarian cancer treatments and research, and to meet others in the ovarian … Continued
News
PARP Inhibitors in Ovarian Cancer Treatment: What’s Next?
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients. As of February 2020, there are currently 3 FDA-approved PARP … Continued
OCRA Earns 4-Star Charity Navigator Rating for Tenth Consecutive Year
OCRA is pleased to announce we have earned our tenth consecutive 4-star rating from Charity Navigator, America’s largest independent charity evaluator. We’re proud to again receive this rating, because it … Continued
OCRA Awards $6.6 Million in Ovarian Cancer Research Grants for 2020
(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape. In 2020, … Continued
OCRA-Funded Research Advances Immunotherapy
(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr. Gitto and … Continued
Ovarian Cancer Community Applauds Congress for Providing $35 Million in Ovarian Cancer Research Funding at the Department of Defense in FY 2020 Spending Bill
WASHINGTON, D.C. – December 20, 2019 – Later today, President Trump is expected to sign into law a spending package that funds the government for the remainder of Fiscal Year … Continued
Woman to Woman Meets Patients When and Where They Need It Most
(December 19, 2019) A cancer diagnosis can bring with it a bevy of complicated responses, including fear, anger, and even guilt. No one should have to navigate these tricky waters … Continued
OCRA-Funded Research Breakthroughs in 2019
OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives. Our grantees have made incredible progress toward … Continued
OCRA Research Reveals Two Cells of Origin for High Grade Ovarian Cancer
(December 3, 2019) The origins of high grade serous ovarian carcinoma (HGSOC) is a debated topic in the scientific community. Prior research has suggested the cancer arises from the fallopian … Continued
A Holiday Message From Audra Moran
Friends, The day before Thanksgiving is a busy one for me, and I imagine, for you too. But before I turn my attention to holiday prep, I wanted to sit … Continued
#GivingTuesday is December 3rd — Join Us in #GivingTeal
(November 25, 2019) This Giving Tuesday, we need your help to make a big impact. For the 22,000 American women diagnosed with ovarian cancer every year, and the 200,000 living … Continued
OCRA-Funded Research Yields Insight into Clear Cell Ovarian Cancers
(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct … Continued